Outcome of a thorough screening of lower urinary tract function in all pediatric kidney recipients.
Liesbeth Lilian De WallLoes OomenFemke Glaap-RoevenWout Fransiscus FeitzCharlotte Magdalena Hubertus Hubertina Theodorus Bootsma-RobroeksPublished in: Pediatric transplantation (2020)
LUTD is one of the possible factors influencing pediatric kidney graft outcomes. This study evaluates the results of a thorough assessment of voiding behavior in pediatric transplants. Data of patients with kidney disease of nephrological origin are compared to those with urological origin. A single-center analysis of pediatric kidney transplants performed from 2005 to the present was executed. Donor and recipient characteristics as well as voiding and drinking habits were documented using FVCs and uroflowmetry with PVR measurements. LUTD was defined by a mean MVV >150% or <65% of the EBC for age, abnormal uroflowmetry, PVR repeatedly >15% of EBC or >20 mL, abnormal voiding patterns or behavior, and presence of LUT symptoms. LUTD was diagnosed in 71% of the 56 screened children and more present in urological origin of kidney disease (100%) compared to nephrological origin (61%, P = .005). Individual presence of LUT symptoms, abnormal voiding behavior, FVC parameters, UTIs, and uroflowmetry/PVR parameters were not different between the two groups. Polyuria after transplantation was seen in 63% of patients, mainly in the first post-transplant years and recipients aged <10 years. Time after transplantation was a significant independent predictive factor for the presence of LUTD. LUTD is common in all pediatric kidney recipients and underestimated in those with a nephrological origin of disease. Active screening, monitoring and a care attention plan prior to transplantation and during follow-up, is advocated to optimize outcomes for all patients.
Keyphrases
- end stage renal disease
- urinary tract
- ejection fraction
- newly diagnosed
- healthcare
- young adults
- peritoneal dialysis
- prognostic factors
- type diabetes
- palliative care
- stem cells
- kidney transplantation
- cell therapy
- electronic health record
- mesenchymal stem cells
- patient reported outcomes
- working memory
- physical activity
- insulin resistance
- quality improvement
- childhood cancer
- weight loss
- pain management